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Objectives The purpose of this study was to evaluate the prevalence of occult coronary artery disease (CAD) with coronary
computed tomography angiography (CTA) to characterize plaque composition and to evaluate the potential of
this new technology to impact risk stratification in asymptomatic middle-aged subjects.
Background There is a paucity of information regarding the role of CTA for the detection of occult CAD in asymptomatic
individuals.
Methods We consecutively enrolled 1,000 middle-aged asymptomatic subjects (age 50  9 years, 63% men) who under-
went CTA (64-slice multidetector row computed tomography) as part of a general health evaluation.
Results Atherosclerotic plaques were identified in 215 (22%, 2  1 segments/subject) individuals; 40 individuals (4%)
had only noncalcified plaques. Fifty-two (5%) subjects had significant (50%) diameter stenosis and 21 (2%)
had severe (75%) stenosis. Thirteen (25%) and 30 (58%) subjects with significant stenosis were classified into
National Cholesterol Education Program low-risk and mild coronary calcification (coronary artery calcium scores
100), respectively. Midterm follow-up (17  2 months) revealed 15 cardiac events only in those with CAD on
CTA: 1 unstable angina requiring hospital stay and 14 revascularization procedures. Most (87%) events occurred
within 90 days of index CTA.
Conclusions The prevalence of occult CAD in apparently healthy individuals was not negligible, although their midterm prog-
nosis was good. CTA has a potential to provide a better insight about the occult CAD in this population. However,
on the basis of our results and considering present radiation exposure data, we cannot recommend that CTA be
used as a screening tool for this population at this point. (Subclinical COronary Atheroscleorosis Updated With
Coronary cT Angiography [SCOUT Study]; NCT00431860) (J Am Coll Cardiol 2008;52:357–65) © 2008 by the
American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.02.086t
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mlarge proportion of patients with sudden cardiac death or
onfatal myocardial infarction do not experience prior symp-
oms of chest pain or exertional dyspnea, emphasizing the
mportance of early detection and treatment of underlying
ubclinical coronary atherosclerosis (1). Cardiovascular pre-
ention algorithms based on traditional risk factors for
oronary artery disease (CAD) often underestimate event
isk, especially in women and in young individuals (2,3).
rom the *Division of Cardiology and †Division of Radiology, Cardiovascular
enter, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do,
outh Korea; ‡Division of Cardiology, Johns Hopkins University School of Medicine,
altimore, Maryland; and §Massachusetts General Hospital Cardiac MRI, PET, CT
rogram, Boston, Massachusetts. Drs. Eue-Keun Choi and Sang Il Choi contributed
qually to this study.o
Manuscript received October 29, 2007; revised manuscript received January 16,
008, accepted February 13, 2008.Evidence supporting the use of noninvasive imaging tests
o screen for CAD is gradually accumulating. The identifi-
ation and quantification of coronary artery calcium (CAC),
marker of subclinical atherosclerosis, provides incremental
rognostic information in addition to the assessment of
onventional risk factors (4,5). However, CAC does not
epresent the whole spectrum of atherosclerosis and has a
imitation to diagnose obstructive CAD (6).
See page 366
With the advent of multi-slice computed tomography
echnology, coronary computed tomography angiography
CTA) has the potential to provide comprehensive infor-
ation regarding the location, severity, and characteristicsf atherosclerotic plaque. Despite the absence of evidence,
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CTA as Screening Tool in Asymptomatic Subjects July 29, 2008:357–65the use of CTA as a screening
tool has been already initiated,
not only through physician
decision-making but through the
mechanism of self-referral (7,8).
To date, there is a paucity of
data regarding the prevalence
and characteristics of CAD in
asymptomatic subjects and any
potential role of CTA to screen
these asymptomatic individuals
for occult disease. In this study,
first, we evaluated the prevalence
of subclinical coronary athero-
sclerosis and outlined coronary
plaque composition in a group of
asymptomatic apparently healthy
South Korean individuals with
CTA, and second, we tried to
identify whether CTA has the
potential to identify individuals
at risk more accurately than
conventional risk stratification
methods.
ethods
tudy population. We retrospectively enrolled 1,074 con-
ecutive South Korean individuals who had undergone
TA evaluation with 64-slice multidetector row computed
omography (MDCT) for general routine health evaluation
n Seoul National University Bundang Hospital (SNUBH)
rom December 2005 and May 2006. We excluded 74
ubjects who had chest pain or discomfort before enrollment
ithout a previous diagnostic workup to rule out CAD (n
), a history of myocardial infarction/angina (n  25),
istory of percutaneous coronary intervention (PCI) (n 
), age under 35 or over 75 years old (n 39), or insufficient
edical records (n  6). As a result, a total of 1,000
elf-referred middle-aged asymptomatic subjects were fi-
ally enrolled. The institutional review board approved the
tudy protocol, and all patients gave written, informed consent.
isk factor assessment and stratification. Basic demo-
raphic data was acquired from a database maintained by
he SNUBH Health Promotion Center. All individuals
ere asked whether they had chest pain or equivalent
ymptoms according to a Rose angina questionnaire (9).
edical history of myocardial infarction, angina, hyperten-
ion, stroke, diabetes mellitus, family history of premature
HD (CHD in male first-degree relative age 55 years;
HD in female first-degree relative age 65 years), current
edication profile, smoking, and social status were system-
tically acquired. Body weight, height, and blood pressure
ere also measured during their visit. Hypertension was
efined as a self-reported history of hypertension and/or use
Abbreviations
and Acronyms
CAC  coronary artery
calcium
CACS  coronary artery
calcium score(s)
CAD  coronary artery
disease
CAG  coronary
angiography
CHD  coronary heart
disease
CTA  computed
tomography angiography
LAD  left anterior
descending artery
MDCT  multidetector row
computed tomography
NCEP  National
Cholesterol Education
Program
PCI  percutaneous
coronary interventionf antihypertensive medication or a blood pressure140/90 fm Hg. Total cholesterol, triglyceride, high-density li-
oprotein cholesterol, low-density lipoprotein cholesterol,
asting plasma glucose, glycated hemoglobin, blood urea
itrogen, and serum creatinine level were measured after at
east a 12-h fasting period on the same day of the study.
iabetes was defined as a self-reported history of diabetes
nd/or receiving antidiabetic treatment or a fasting plasma
lucose 126 mg/dl. Serum C-reactive protein was mea-
ured by latex agglutination with an auto-analyzer
Toshiba-200 FR, Tokyo, Japan). Framingham risk scores,
s used by National Cholesterol Education Program
NCEP) guidelines, were calculated (10).
All subjects were assigned to 3 different risk groups
ccording to the revised NCEP guidelines: high-risk (cor-
nary heart disease [CHD], CHD risk equivalents, or
0-year risk20%), moderate-risk (more than 2 risk factors
nd 10-year risk 20%), and low-risk group (0 to 1 risk
actor) (10).
ata acquisition. Patients with a heart rate70 beats/min
eceived intravenous esmolol, 10 to 30 mg (Jeil Pharm. Co.,
td., Seoul, Korea), before MDCT imaging. The CTA was
erformed with the use of a 64-slice MDCT scanner
Brilliance 64, Philips Medical Systems, Best, the Nether-
ands). A standard scanning protocol was applied, with 64 
.625 mm section collimation, 420-ms rotation time,
20-kV tube voltage, 800-mA tube current. All scans were
erformed with electrocardiogram-gated dose modulation.
bolus of 80 ml Iomeprol (Iomeron 400, Bracco, Milan,
taly) was intravenously injected (4 ml/s) followed by a
0-ml saline chaser.
A region of interest was placed in the descending thoracic
orta, and image acquisition was automatically initiated
nce a selected threshold (150 Hounsfield units [HU]) had
een reached with bolus tracking. The patient’s electrocar-
iogram was simultaneously recorded to allow for retrospec-
ive segmental data reconstruction. Images were initially
econstructed at mid-diastolic phase (75% of R-R interval)
f the cardiac cycle. Additional reconstructions were per-
ormed if motion artifacts were present. The mean radiation
xposure of CTA was 13.21 0.82 mSv (13.21 0.83 mSv
or men and 13.33  0.79 mSv for women).
mage analysis. All scans were analyzed independently by
experienced radiologists (S.I.C. 5 years; E.J.C. 3 years)
ho were blinded to the clinical information with a
-dimensional workstation (Brilliance, Philips Medical Sys-
ems, Best, the Netherlands). After making independent
valuations, a consensus interpretation was arrived at to
btain a final MDCT diagnosis. Each lesion was identified
ith a multiplanar reconstruction technique and maximum
ntensity projection of short-axis, 2-chamber, and 4-chamber
iews. We analyzed plaque characteristics on a per-segment
asis according to the modified American Heart Association
lassification (11). Image quality was evaluated on a per-
egment basis and classified as good (no artifact), adequate
defined as the presence of image-degrading artifacts but
easible for evaluation with a moderate confidence), or poor
(
e
w
a
r
c
c
w
4
i
s
a
g
P
p
a
m
n
w
e
c
m
M
t
o
a
t
c
C
c
o
d
q
f
a
S
m
a
o
t
F
b
t
c
o
p
s
S
R
C
c
a
w
t
g
f
C
c
o
m
a
r
f
a
c
t
w
t
S
c
fi
S
s
r
f
w
s
C
M
t
d
j
l
n
c
n
l
t
C
t
w
p
i
m
s
o
C
l
C
t
(
(
w
359JACC Vol. 52, No. 5, 2008 Choi et al.
July 29, 2008:357–65 CTA as Screening Tool in Asymptomatic Subjectsthe presence of image-degrading artifacts and feasible for
valuation only with a low confidence).
The contrast-enhanced portion of the coronary lumen
as semi-automatically traced at the maximal stenotic site
nd compared with the mean value of proximal and distal
eference site. If the image was adequate or poor quality,
oronary segments were visually scored for the grading of
oronary artery stenosis. The severity of diameter stenosis
as graded as normal-appearing (0% to 24%), mild (25% to
9%), moderate (50% to 74%), and severe (75%) narrow-
ng (12). A stenosis more than 50% and 75% was defined as
ignificant and severe, respectively.
Plaques were defined as structures 1 mm2 within and/or
djacent to the vessel lumen, which could be clearly distin-
uished from the lumen and surrounding pericardial tissue.
laques occupied by calcified tissue more than 50% of the
laque area (density 130 HU in native scans) were classified
s calcified, plaques with 50% calcium were classified as
ixed, and plaques without any calcium were classified as
oncalcified lesions (13).
Coronary artery calcium scores (CACS) were measured
ith the scoring system previously described by Agatston
t al. (14,15). Participants, on the basis of the CACS, were
ategorized in the following manner: no, 0; mild, 0.1 to 100;
oderate, 100.1 to 400; and severe calcification, 400.
idterm clinical outcome and secondary diagnostic
ests. Follow-up data were obtained from medical records
r telephone contact with trained personnel. Subjects were
sked the occurrence of new chest pain, subsequent diagnostic
est (i.e., single-photon emission computed tomography or
oronary angiography [CAG] within 90 days after index
TA), and subsequent revascularization therapy (PCI or
oronary artery bypass graft surgery) on the basis of index CTA
r cardiac events. Cardiac events were defined as: cardiac
eath, nonfatal myocardial infarction, unstable angina re-
uiring hospital stay, or revascularization therapy. Clinical
ollow-up (17  2 months [range 12 to 21 months]) was
vailable in 97.4% of cases.
tatistical analysis. Continuous variables are expressed as
eans  SD, whereas categorical variables are presented as
bsolute values and percentages. Differences between continu-
us variables were analyzed by the unpaired Student t test and
hose between categorical variables by the chi-square test or
isher exact test, as appropriate. We analyzed the relationship
etween age (quartiles) and indexes of CAD with chi-square
esting for trend. Multiple logistic regression analysis (forward
onditional) was employed to identify independent predictors
f the presence of plaque, significant stenosis, and noncalcified
laque only on CTA. A p value of 0.05 was considered
tatistically significant, and all analyses were performed with
PSS 13.0 statistical package (SPSS Inc., Chicago, Illinois).
esults
linical characteristics of asymptomatic population. The
linical characteristics of the population according to gender nre listed in Table 1. The mean age of the study population
as 50 9 years (range 35 to 74 years), 63% were men, and
he mean number of risk factors on the basis of NCEP
uidelines was 1  1 (range 0 to 4) with 2 or more risk
actors observed in 41% of subjects.
TA imaging. Image quality of coronary arteries was
lassified as good in 94%, adequate in 4%, and poor in 1%
n a segmental basis. Reasons for poor image quality were
otion artifact (55%, 121 of 219 segments), blooming
rtifact (29%, 64 of 219 segments), or low contrast-to-noise
atio (16%, 34 of 219 segments). Interobserver agreement
or the degree of stenosis was 0.87, indicating very good
greement. Only vessels providing good image quality were
onsidered for plaque analysis. Inter-observer agreement for
he detection of any plaque/subject and plaque/segment
ere excellent (Cohen’s kappa  0.93 and 0.84, respec-
ively), comparable to the previous study (16).
ubclinical coronary atherosclerosis—prevalence and
haracteristics of atherosclerotic plaques. Coronary calci-
cations were present in 175 of 1,000 (18%) patients (Fig. 1).
ubsequent CTA revealed atherosclerotic plaques in 392
egments from 215 (22%) subjects (2  1 segments/subject;
ange 1 to 6). Although mixed plaques emerged as the most
requent type of atherosclerotic plaque, noncalcified plaque
as found in at least 1 coronary artery segment in 80
ubjects (8%).
Fifty-two (5%) subjects had a significant stenosis on
TA, and 21 (40%) of them had severe stenosis (Table 2).
ost of them had single-vessel disease (73%), and most of
he significant lesions were located in the left anterior
escending coronary artery (LAD) (85%). In 77% of sub-
ects who had a significant stenosis, lesions were located on
eft main or proximal to mid-LAD.
The incidence of atherosclerotic plaques, significant ste-
osis, and moderate-to-severe coronary calcification in-
reased with age (Fig. 2). In contrast, the proportion of
oncalcified plaque in total plaques at each age quartile was
owest in the oldest one (46% vs. 53% vs. 39% vs. 21%, p for
rend  0.019).
Noncalcified plaques were the only manifestation of
AD in 40 subjects (4%, 1  0.4 segments/subject; range 1
o 3 segments/subject). They were younger than the subjects
ith other types of plaques (51  8 years vs. 56  9 years,
 0.001). Almost all (38, 95%) of them were classified
nto low and moderate risk group, and most of them were
ale (33, 83%). Their proportion and location of significant
tenosis was not different from the subjects with other types
f plaques: 10 (25%) subjects had significant stenosis on
TA, 5 (50%) of them had severe stenosis, and 70% (7) of
esions were located on left main or proximal to mid-LAD.
omparing within the subjects with 0 CACS (n  825),
hose with noncalcified plaques only (n  40) were older
51  8 years vs. 48  8 years, p  0.05) and mostly male
83% vs. 57%, p  0.01). Subgroup analysis within those
ith 0 CACS, 2% of men had significant stenosis, whereas
o woman had significant stenosis.
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CTA as Screening Tool in Asymptomatic Subjects July 29, 2008:357–65In univariate and multivariate analysis, most of conven-
ional risk factors could not independently predict the
resence of plaques, significant stenosis, and noncalcified
Characteristics of CTA Study Group
Table 1 Characteristics of CTA Study Group
Characteristics
Total
(n  1,000)
Age, yrs 49.7 8.8
BMI, kg/m2 24.1 2.7
Systolic blood pressure, mm Hg 115.8 14.2
Diastolic blood pressure, mm Hg 74.3 11.6
Hypertension 246 (24.6)
Diabetes mellitus 73 (7.3)
Hypercholesterolemia 141 (14.1)
History of stroke 12 (1.2)
Family history of premature CAD 129 (12.9)
Smoking 331 (33.3)
Total cholesterol, mg/dl 204.8 34.3
LDL cholesterol, mg/dl 118.0 32.2
HDL cholesterol, mg/dl 60.1 14.2
Triglyceride, mg/dl 133.7 89.9
Fasting blood glucose, mg/dl 97.6 24.8
Glycated hemoglobin, % 5.8 0.8
BUN, mg/dl 13.1 3.4
Serum creatinine, mg/dl 1.1 0.2
CRP, mg/dl 0.13 0.33
FRS, average 5.2 5.0
NCEP-ATP III risk stratification
High-risk group 102 (10.2)
Moderate-risk group 341 (34.1)
Low-risk group 557 (55.7)
CACS (range) 17.6 82.5 (0–1,15
Data are expressed as n (%) and mean  SD. *p  0.05.
BMI  body mass index; BUN  blood urea nitrogen; CACS  coro
protein; CTA  computed tomography angiography; FRS  Framingha
NCEP-ATP  National Cholesterol Education Program-Adult Treatmen
Figure 1 Study Population on the Basis of the Results of Coron
CAD  coronary artery disease; CT  computed tomography; MDCT  multidetectlaques as the only manifestation of CAD on CTA
Table 3). Age (decade), male gender, and C-reactive
rotein were independent predictors for presence of any
Male
(n  626)
Female
(n  374)
48.9 8.4* 51.0 9.3
24.8 2.5* 23.0 2.7
117.6 13.7* 112.8 14.6
77.7 10.3* 68.6 11.5
177 (28.3)* 69 (18.4)
56 (8.9)* 17 (4.5)
104 (16.6)* 37 (9.9)
5 (0.8) 7 (1.8)
83 (13.3) 46 (12.3)
314 (50.2)* 17 (4.6)
205.7 32.9 203.4 36.6
117.9 31.5 118.1 33.5
56.7 12.8* 65.9 14.6
155.8 99.3* 96.8 54.1
100.7 27.8* 92.3 17.5
5.8 0.8* 5.7 0.7
13.6 3.5* 12.1 3.1
1.2 0.1* 0.9 0.1
0.15 0.38* 0.10 0.21
7.4 5.2* 1.6 1.3
75 (12.0)* 57 (7.2)
290 (46.3)* 51 (13.6)
261 (41.7)* 296 (79.1)
24.9 101.2* (0–1,151.4) 5.3 29.0 (0–313.5)
ery calcium score; CAD  coronary artery disease; CRP  C-reactive
score; HDL  high-density lipoprotein; LDL  low-density lipoprotein;
m.
rtery Calcium Scoring and CT Angiography
computed tomography; pts  patients.1.4)
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July 29, 2008:357–65 CTA as Screening Tool in Asymptomatic Subjectslaque and noncalcified plaque only, whereas male gender
nd CAC category were independent predictors for signif-
cant stenosis.
ignificant subclinical coronary atherosclerosis—relation
ith NCEP risk stratification and CACS according to
ges. The prevalence of significant stenosis in low-,
oderate-, and high-risk group were 2%, 7%, and 16%,
espectively. Dividing those with significant stenosis accord-
ng to ages reveals: young adults (age55 years for male and
esults of CTA According to Gender
Table 2 Results of CTA According to Gender
Characteristic, n (%)
Total
(n  1,000)
Male
(n  626)
Female
(n  374)
Any plaques 215 (21.5) 177 (28.3)* 38 (10.2)
Significant stenosis† 52 (5.2) 48 (7.7)* 4 (1.1)
Number of stenosed vessels‡
1-vessel 38 (3.8) 35 (5.6)* 3 (0.8)
2-vessel§ 11 (1.1) 11 (1.8)* 0 (0)
3-vessel§ 3 (0.3) 2 (0.3)* 1 (0.3)
Maximal diameter stenosis
0%–24% 896 (89.6) 540 (86.3)* 356 (95.2)
25%–49% 52 (5.2) 38 (6.1) 14 (3.7)
50%–74% 31 (3.1) 29 (4.6)* 2 (0.5)
75%–100% 21 (2.1) 19 (3.0)* 2 (0.5)
CACS
0 825 (82.5) 482 (77.0)* 343 (91.7)
0.1–100 128 (12.8) 104 (16.6)* 24 (6.4)
100.1–400 37 (3.7) 30 (4.8)* 7 (1.9)
400§ 10 (1.0) 10 (1.6)* 0 (0)
Plaques (per-subject)
No plaques 785 (78.5) 449 (71.7)* 336 (89.8)
Noncalcified plaque only 40 (4.0) 33 (5.3)* 7 (1.9)
Noncalcified or mixed plaque 84 (8.4) 67 (10.7)* 17 (4.5)
Calcified plaque 91 (9.1) 77 (12.3)* 14 (3.7)
p  0.05; †luminal diameter stenosis 50%; ‡diseased vessel having significant luminal
iameter stenosis; §Fisher exact test was used.
CACS  coronary artery calcium score; CTA  computed tomography angiography.
0%
10%
20%
30%
40%
50%
Non-cal
plaqu
Any plaques Significant 
stenosis
All, p < 0.001
Figure 2 Coronary Artery Disease According to Age Quartiles
The incidence of atherosclerotic plaques, significant stenosis, and moderate-to-sege 65 years for female) had lower prevalence of signifi-
ant stenosis compared with old adults (4% vs. 14%, p 
.001), and younger adults (age 45 years for male and age
55 years for female) had extremely low prevalence of
ignificant stenosis (0.9%).
However, 13 (25%) subjects with significant stenosis were
lassified into low risk, which was more pronounced in
oung adults than in older ones (31% vs. 17%) (Fig. 3A).
urthermore, two-thirds (n  20) of young adults with
ignificant stenosis had CACS lower than 100, and only 7%
ad CACS higher than 400, compared with 43% and 17%
f old adults, respectively (Fig. 3B). Even stratifying the
ow-risk subjects combined with CACS (100), 28% (8)
nd 13% (3) of the significant stenosis in young and older
dults were missed, respectively.
idterm outcome and secondary test of asymptomatic
opulation according to CTA results. In those with
AD (n  215), 15 subjects had cardiac events: no cardiac
eath, 1 unstable angina requiring hospital stay, and 14
evascularization procedures (13 in PCI and 1 in coronary
rtery bypass graft surgery). Most cardiac events (87%) (i.e.,
3 revascularization procedures) occurred, on the basis of
TA results, within 90 days of index CTA except 1, which
ccurred for unstable angina without revascularization ther-
py. Thirty-one subjects (14%) underwent additional diag-
ostic testing on the basis of CTA results within 90 days of
ndex CTA: myocardial single-photon emission computed
omography in 9 subjects (4%), CAG in 23 subjects (11%),
nd both tests in 1 subject (0.1%). As a consequence, 20
atients (2% of the total cohort) were confirmed to have a
ignificant stenosis on the basis of the CAG. Severe stenosis
as found in 16 patients (1.6% of the total cohort), 7 had
ultivessel disease, and 7 had single-vessel disease mostly in
he proximal LAD (Fig. 4). In those with noncalcified
laque only (n  40), 2 subjects (5%) had cardiac events: 1
Quartile 4 (˻ 57 yrs) (n=239)
Quartile 3 (48 – 56 yrs) (n=262)
Quartile 2 (44 – 47yrs) (n=228)
Quartile 1 (˺ 43 yrs) (n=271)
Calcified 
plaques
Mixed       
plaques
Age
High CACS 
( >100)
ronary calcification increased with age. CACS  coronary artery calcium scores.cified 
es
vere co
Predictors of Subclinical Coronary Atherosclerosis on CTA
Table 3 Predictors of Subclinical Coronary Atherosclerosis on CTA
Any Plaque (n  215) Significant Stenosis (n  52) Noncalcified Plaque Only (n  40)
Univariate Multivariate* Univariate Multivariate* Univariate Multivariate*
p Value OR (95% CI) p Value OR (95% CI) p Value OR (95% CI) p Value OR (95% CI) p Value OR (95% CI) p Value OR (95% CI)
Age (decade) 0.001 2.31 (1.95–2.74) 0.001 1.84 (1.28–2.64) 0.001 2.00 (1.50–2.66) — — 0.196 1.24 (0.90–1.72) 0.001 1.84 (1.30–2.64)
Male gender 0.001 3.49 (2.39–5.09) 0.001 4.26 (1.80–10.08) 0.001 7.68 (2.75–21.48) 0.006 5.45 (1.62–18.35) 0.011 2.92 (1.28–6.66) 0.001 4.26 (1.80–10.08)
BMI, kg/m2 0.001 1.11 (1.05–1.17) — — 0.033 1.12 (1.01–1.24) — — 0.224 1.07 (0.96–1.21) — —
Systolic blood pressure,
mm Hg
0.001 1.03 (1.02–1.04) — — 0.003 1.03 (1.01–1.05) — — 0.830 1.00 (0.98–1.03) — —
Diastolic blood
pressure, mm Hg
0.001 1.03 (1.02–1.05) — — 0.014 1.03 (1.01–1.06) — — 0.109 1.02 (1.00–1.05) — —
Hypertension 0.001 2.40 (1.74–3.32) — — 0.001 2.80 (1.59–4.94) — — 0.753 1.13 (0.53–2.41) — —
Diabetes mellitus 0.001 2.80 (1.71–4.58) — — 0.001 3.35 (1.60–6.98) — — 0.259 3.16 (0.43–23.4) — —
Smoking 0.025 1.43 (1.05–1.96) — — 0.010 2.09 (1.19–3.66) — — 0.816 1.08 (0.56–2.10) — —
Triglyceride, mg/dl 0.001 1.00 (1.00–1.01) — — 0.005 1.00 (1.00–1.01) — — 0.856 1.00 (1.00–1.00) — —
Fasting blood glucose,
mg/dl
0.001 1.01 (1.01–1.02) — — 0.002 1.01 (1.00–1.02) — — 0.348 0.99 (0.98–1.01) — —
Glycated hemoglobin, % 0.001 1.57 (1.31–1.88) — — 0.001 1.66 (1.30–2.11) — — 0.196 0.68 (0.38–1.22) — —
BUN, mg/dl 0.001 1.10 (1.05–1.15) — — 0.008 1.10 (1.03–1.19) — — 0.269 1.05 (0.96–1.15) — —
Serum creatinine, mg/
dl
0.001 10.87 (4.40–26.87) — — 0.001 11.87 (2.81–50.1) — — 0.051 4.80 (1.00–23.2) — —
FRS, average 0.001 1.14 (1.11–1.18) — — 0.001 1.15 (1.10–1.20) — — 0.322 1.03 (0.97–1.09) — —
CACS category† — — — — 0.001 6.49 (4.50–9.35) 0.001 5.91 (4.02–8.68) — — — —
CRP, mg/dl 0.001 2.61 (1.47–4.64) 0.007 3.33 (1.39–8.00) 0.302 1.34 (0.77–2.33) — — 0.014 1.81 (1.13–2.90) 0.007 3.33 (1.39–8.00)
*Forward conditional multiple logistic regression analysis adjusting with age (decade), male gender, BMI, systolic blood pressure, diastolic blood pressure, hypertension, diabetes mellitus, smoking, triglyceride, fasting blood glucose, glycated hemoglobin, BUN, serum
creatinine, FRS, CRP, and CACS category. †CACS category: 0, 0.1–100, 100.1–400, and 400.
CI  confidence interval; OR  odds ratio; other abbreviations as in Table 1.
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July 29, 2008:357–65 CTA as Screening Tool in Asymptomatic Subjectsnstable angina requiring hospital stay, and 1 revasculariza-
ion procedure (PCI).
In those without CAD (n 785; high-risk vs. moderate-
isk vs. low-risk  7% vs. 30% vs. 63%), there were no
ardiac events during the follow-up period. Twenty-eight
4%) subjects complained of new chest pain after CTA
valuation; however, no further diagnostic test was per-
ormed on those subjects during the follow-up period.
iscussion
he main findings of the present study are the following: 1)
significant percentage of the population (22%) had evi-
ence of occult CAD despite the absence of symptoms, and
f those, 5% had at least 1 significant coronary artery
tenosis; 2) in 4% of the subjects the presence of noncalci-
ed plaques was the only manifestation of CAD; 3) 25% of
ubjects with significant stenosis were classified into low
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score (CACS). Young adults with significant stenosis were classified into low risk a
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Figure 4 Multidetector Row Computed Tomography and Corona
Curved multiplanar imaging (A) shows significant lesion located in the left anterior
Cross-sectional view (B) of dashed line in A demonstrates severe positive arterial
stenosis (degree of stenosis: 80%) located in the proximal left anterior descendin
sponding area of left anterior descending artery (arrow).isk, which was more pronounced in young adults; and 4)
ndividuals with a normal CTA had excellent clinical
utcomes and underwent few additional diagnostic tests
uring mid-term follow-up, whereas those with CAD on
TA had all of the cardiac events and subsequent diagnostic
ests.
haracteristics of subclinical coronary atherosclerosis—
revalence and plaque characteristics. Our knowledge
ith regard to the prevalence of occult CAD in asymptom-
tic individuals is limited. According to earlier observations,
he prevalence of CAD confirmed by CAG in asymptom-
tic individuals is approximately 3% to 5% (17–19). Al-
hough CAG is generally accepted as the clinical gold
tandard for diagnosing the presence of CAD and plaque
haracterization in conjunction with intravascular ultra-
ound, it is difficult to use CAG as a screening test in
symptomatic subjects due to its highly invasive nature.
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CTA as Screening Tool in Asymptomatic Subjects July 29, 2008:357–65ecause most underlying plaques are nonstenotic and acute
oronary events are caused by plaque rupture, the concept of
sing noninvasive imaging methods that permit detection,
uantification, and possibly also characterization of coro-
ary atherosclerotic plaques to carry out individualized risk
tratification is intriguing.
Computed tomography technology can provide compre-
ensive information on CAD, such as lesion location,
everity, and plaque characteristics (12,20–22). In our study,
therosclerotic plaques were identified in 22% of asymptom-
tic subjects; 18% of those with any plaque had only
oncalcified plaques, whereas overall it was seen only in 4%
f the total population. Even in the absence of symptoms,
2 (5%) subjects had significant (50%) diameter stenosis,
nd of those, 21 (40%) had severe (75%) stenosis. Inter-
stingly, in 77% of subjects who had a significant stenosis
nd 61% (239) of plaques, lesions were located on the left
ain or proximal to mid-LAD. A previous study by Min
t al. (23) demonstrated that the presence of left main or
roximal LAD atherosclerotic disease as evidenced by CTA
n symptomatic subjects is associated with a worse progno-
is. Whether this association can be extrapolated to asymp-
omatic individuals remains to be seen.
ole of CTA in asymptomatic population: additional role to
onventional NCEP risk stratification or CACS? Although
pecific algorithms based on the classical cardiovascular risk
actors have been used to identify individuals at risk, they
ave limited predictive power for the development of
ardiovascular events (24). In general, CAC does reflect
laque burden and therefore remains an unequivocal bio-
arker for the presence and extent of atherosclerotic disease
25). Coronary artery calcium provides incremental prog-
ostic information over traditional risk factors and recently
as proposed as an index parameter of routine screening
specially among those with intermediate risk (26,27).
The NCEP III primary prevention guidelines on the
asis of classical risk factors tend to underestimate the
ardiovascular event risk in young adults (3). Furthermore,
ecent studies have demonstrated that 7% to 17% of
ymptomatic patients with a very low CACS have obstruc-
ive CAD and 6% of patients with an intermediate risk for
aving CAD had only noncalcified plaques (12,28). We
ound, in concordance with previous studies, that CTA could
etect significant stenosis, especially in young adults, who
ight be misclassified by NCEP risk stratification, CACS,
r combined but in only few percentages of individuals.
mpact of CTA on additional test and treatment, and the
isk of radiation hazard. Although the American Heart
ssociation and the American College of Cardiology have
iscouraged the use of MDCT as a screening procedure in
symptomatic subjects, mass-media and market forces have
acilitated self-referral within the general public. In our
tudy, 3% of asymptomatic individuals received at least 1
urther diagnostic test on the basis of their CTA results and,
4nally, 1% of the total population received revascularization
herapy due to significant stenosis on CAG. The triggering
f more diagnostic studies, especially in this low-risk pop-
lation, might introduce more risk than health benefit and
ould potentially increase overall health care expenditure.
The Food and Drug Administration announced that there is
 small chance (1 in 2,000) of developing a fatal cancer due to
 10-mSv computed tomography study (29). On the basis of
he recent BEIR-VII (Biological Effects of Ionizing Radiation)
tudy, 64-slice MDCT is associated with a non-negligible risk
f cancer, especially in women and in younger patients (30). In
ddition to outcomes data, questions relating to radiation
xposure and cost-effectiveness also remain to be answered
efore CTA could be considered as a routine screening tool for
ccult CAD. However, with the advent of MDCT technol-
gy, the radiation dose for CTA could be minimized to the
evel of background radiation (3 mSv) (31,32). Further
tudies using that technology will have to be done to assess the
easibility of using CTA as a screening tool.
tudy limitations. All subjects in our study were self-
eferred, suggesting that selection bias might intervene.
lso, because all subjects were drawn from the same ethnic
ackground and geographical region, findings from this
tudy should thus be cautiously applied. We excluded,
imilar to other studies, 5% of lesions of the coronary
egments with impaired image quality from plaque analysis.
owever, with ongoing technological developments (i.e.,
ual-source computed tomography with improved temporal
esolution or 256-slice computed tomography with faster
can time), we will expect that image quality will improve,
ermitting assessment of plaque morphology and composition.
onclusions
he prevalence of CAD in asymptomatic individuals was not
egligible, although their midterm prognosis was good. A
umber of individuals with occult CAD might be misclassified
ith conventional risk stratification algorithms. Computed
omography angiography has the potential to identify these
atients, although its risks and benefits with regard to out-
omes in asymptomatic individuals and its cost effectiveness
emain to be seen.
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